 |
|
|
Click here to subscribe to our Magazine
|
 |
 |
Latest Press Releases |
 |
Lilly's Verzenio for Advanced Breast Cancer Receives Additional FDA Approval This additional FDA approval marks the third indication for Verzenio within five months. In September 2017, Verzenio became the first and only cyclin-dependent kinase (CDK)4 & 6 inhibitor approved in combination and as a single agent in metastatic breast cancer.
|
|
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage CHAMPION is investigating whether Ferring's proprietary and heat-stable carbetocin could offer a new solution to prevent excessive bleeding...
|
FDA Approves the World's Smallest Mechanical Heart Valve for Pediatric Patients With Heart Defects Abbott announced the U.S. FDA approved the Masters HP 15mm rotatable mechanical heart valve, the world's smallest mechanical heart valve, that will allow doctors to treat babies and toddlers in need of a mitral or aortic...
|
 |
Latest News |
 |
Cipla and Roche tie-up to sell 2 cancer drugs in India This additional FDA approval marks the third indication for Verzenio within five months. In September 2017, Verzenio became the first and only cyclin-dependent kinase (CDK)4 & 6 inhibitor approved in combination and as a single agent in metastatic breast cancer.
|
|
Haverford Trust Co. elevated its position in shares of Eli Lilly and Co by 16.3% Haverford Trust Co. lifted its position in shares of Eli Lilly and Co by 16.3% during the fourth quarter, according to the company in its most recent filing with the SEC.
|
RAPS announces training programme for 510 (k) submissions featuring former FDA officials The Regulatory Affairs Professionals Society (RAPS) continues its support of medical device professionals in Europe with the launch of a workshop focused on 510 (k) premarket submissions to the US FDA.
|
|
For Advertising Queries: |
For the latest visit: www.worldpharmatoday.com
|